Economy & Business, Health & Environment, Politics

FDA Approves Injecting Children; No Prior Clinical Trials

The U.S. Food and Drug Administration (FDA) on Monday has granted emergency use authorization (EUA) for Pfizer’s mRNA COVID booster shot for use in children as young as 12 years old.

A Monday press release from the FDA detailed the expansion of Pfizer’s booster shot authorization to include children between 12 and 15 years of age and to grant permission for a third shot to be included as part of the “primary series … for certain immunocompromised children 5 through 11 years of age.” The new protocol also reduces the minimum timeframe between reception of a second and third dose of the abortion-tainted jab from six months to five months.

According to Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, the agency based its decision to expand the booster program on its assessment that “currently available data” shows a third dose “may help provide better protection against both the Delta and Omicron variants.”

However, the agency did not consult with its panel of independent experts on the necessity and safety of providing booster jabs to children before giving the green light. The panel had overwhelmingly rejected the Pfizer booster shot for use in healthy people aged 16 and over back in September. Read more…

You Might Also Like